Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis
SMOC2 appears to be a key regulator in the pathogenesis of adenomyosis, promoting ECM remodeling and EMT, both of which are characteristic of the disease. Targeting SMOC2 may provide a novel therapeutic strategy for the treatment of adenomyosis.
Authors
- Liping Han (ORCID: https://orcid.org/0000-0001-6380-2105)
- Shuluo Ning (ORCID: https://orcid.org/0000-0002-0398-6456)
- Shuangjuan Liu
- Lihui Wang (ORCID: https://orcid.org/0000-0001-9805-2965)
- Ming Guo
- Xiaomin Niu (ORCID: https://orcid.org/0000-0003-1079-1785)
- Lin Li (ORCID: https://orcid.org/0000-0002-3111-5965)
- Li Ren (ORCID: https://orcid.org/0000-0002-5283-0300)
- Haoda Lu (ORCID: https://orcid.org/0000-0003-4434-7869)
- Shiwali Vinita
Institutions
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Luoyang Institute of Science and Technology (CN)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1186/s12905-025-03700-8
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00